Summaries
PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
COVID-19 rapid guideline on dermatological conditions
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
NICE COVID-19 management
Summary of NICE guidance on the management of COVID-19 in children, young people, and adults in primary care settings
COVID-19 rapid guideline on systemic anticancer treatments
This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection
PHE management of patient/staff exposure to COVID-19
This summary provides guidance on the management of staff and patients according to exposures, symptoms, and test results
NHS England COVID-19 vaccination SOP
This standard operating procedure (SOP) summary describes the operating model and design requirements for safe delivery of COVID-19 vaccines in the community
NICE ‘long COVID’ guideline
Recommendations for identifying and managing ‘long-COVID’ in primary care
NHS England COVID-19 guidance for community pharmacy
This standard operating procedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation
NHS guidance on NSAIDs in COVID-19
This summary sets out the clinical policy for the acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19.
COVID-19 rapid guideline on COPD
The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.
COVID-19 rapid guideline on severe asthma
The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.